Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist.
J Fam Pract
; 66(10 Suppl): S17-S28, 2017 Oct.
Article
em En
| MEDLINE
| ID: mdl-28991933
ABSTRACT
This article presents the rationale and data for combining a basal insulin with a GLP-1RA, including as fixed-ratio products.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Diabetes Mellitus Tipo 2
/
Insulinas
/
Receptor do Peptídeo Semelhante ao Glucagon 1
/
Hipoglicemiantes
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article